TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
Bionordika AS
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
27,383
|
29,771
|
38,225 |
| Financial expenses |
277
|
517
|
487 |
| Earnings before taxes |
1,482
|
2,363
|
7,807 |
| Total assets |
12,798
|
12,094
|
18,834 |
| Current assets |
12,246
|
11,642
|
18,510 |
| Current liabilities |
7,497
|
7,129
|
13,325 |
| Equity capital |
4,526
|
4,885
|
5,372 |
| - share capital |
64
|
68
|
72 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
35.4%
|
40.4%
|
28.5% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
5.4%
|
7.9%
|
20.4% |
| Return on assets (ROA) |
13.7%
|
23.8%
|
44.0% |
| Current ratio |
163.3%
|
163.3%
|
138.9% |
| Return on equity (ROE) |
32.7%
|
48.4%
|
145.3% |
| Change turnover |
-893
|
-6,105
|
-9,805 |
| Change turnover % |
-3%
|
-17%
|
-20% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.